Compare SRRK & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | GBDC |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2018 | 2010 |
| Metric | SRRK | GBDC |
|---|---|---|
| Price | $45.94 | $13.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $47.88 | $14.83 |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 11-14-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 11.85% |
| EPS Growth | N/A | ★ 4.09 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $870,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20,271.77 | N/A |
| P/E Ratio | ★ N/A | $9.53 |
| Revenue Growth | N/A | ★ 20.16 |
| 52 Week Low | $22.71 | $12.68 |
| 52 Week High | $48.28 | $16.01 |
| Indicator | SRRK | GBDC |
|---|---|---|
| Relative Strength Index (RSI) | 63.42 | 31.65 |
| Support Level | $42.61 | $13.37 |
| Resistance Level | $45.32 | $13.74 |
| Average True Range (ATR) | 2.02 | 0.18 |
| MACD | -0.36 | -0.08 |
| Stochastic Oscillator | 60.51 | 0.48 |
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.